you are in demo mode.    to view your own genetic profile, order your scan now.

Site search

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

This report is for females of European ancestry, which does not match your settings for males of European ancestry. The results may therefore not be applicable for you.

Recent changes:
Oct 29 2009, 10:50 AM Added one risk variant for Europeans

Breast Cancer

Breast cancer is by far the most common cancer affecting women worldwide, and it is the most common cause of cancer death in women.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity: 

Gender:    Female

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

change

Female

Trait_male_female



Bcrs
According to the selected literature, the relative genetic risk calculated from your genotype for females of European ancestry is 0.69. This corresponds to a 8.3% lifetime risk of developing breast cancer, which is 31% less than for females of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 8 of every 100 females of European ancestry with your genotype variants develop this disease in their lifetime.
Bcrs
The average lifetime risk
On average, about 12 of every 100 females of European ancestry develop this disease in their lifetime.
Bcrs

Consult with our experts

Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Breast Cancer

Keep in mind

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).